Luminol sodium
Tier C — Watch / tradeLuminol sodium
Targets：IL6, TNFα
Indications (approved)：免疫紊乱, Psoriasis
Regional status
Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Luminol | 521-31-3 | 5-amino-2,3-dihydrophthalazine-1,4-dione |
| LUMI-001 | 603-11-2 | 3-nitrophthalic acid |
| LUMI-002 | 3682-15-3 | 5-nitro-2,3-dihydrophthalazine-1,4-dione |
| Luminol sodium | 20666-12-0 | - |
Frequently asked questions
What are the approved indications of Luminol sodium?
Approved indications include: 免疫紊乱, Psoriasis.
When does the Luminol sodium patent expire?
No public expiry year is available for Luminol sodium yet; this page updates once verified.
How many synthesis routes are recorded for Luminol sodium?
2 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Luminol sodium intermediates?
All intermediates in Luminol sodium routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Luminol sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29